
Shares of Rubrik, Inc. RBRK rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued first-quarter guidance above estimates.
Rubrik reported quarterly losses of 61 cents per share, which beat the analyst consensus estimate for losses of 80 cents. Quarterly revenue clocked in at $258.1 million, which beat the analyst consensus estimate of $233.1 million.
Rubrik shares climbed 20.8% to $66.84 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Radius Recycling, Inc. RDUS rose 108.7% to $28.51 in pre-market trading after the company agreed to be acquired by US subsidiary of Toyota Tsusho for $30.00 per share in cash.
- Applied Optoelectronics, Inc. AAOI gained 56.5% to $24.83 in pre-market trading after the company announced a warrant issuance agreement transaction with Amazon for 7,945,399 shares.
- MEDIROM Healthcare Technologies Inc. MRM gained 48.6% to $0.91 in pre-market trading. MEDIROM Mother Labs executive made an additional investment in Mother Labs’ Series A financing at a pre-money valuation of JPY9 billion.
- Cellectis S.A. CLLS gained 40.3% to $1.81 in pre-market trading after the company announced upbeat financial results for the fourth quarter.
- Bit Origin Ltd BTOG gained 37.2% to $0.3743 in pre-market trading after declining 26% on Thursday.
- Digital Ally, Inc. DGLY gained 23.2% to $0.0978 in pre-market trading. Digital Ally has been granted six new patents covering diverse sectors.
- TransCode Therapeutics, Inc. RNAZ rose 19% to 0.8827. TransCode Therapeutics, on Thursday, announced Safety Review Committee approval to open a fourth cohort of its Phase I/II Clinical trial of TTX-MC138.
- DocuSign, Inc. DOCU gained 12.2% to $83.75 in pre-market following better-than-expected fourth-quarter financial results.
- Ulta Beauty, Inc. ULTA rose 7% to $336.26 in pre-market trading as the company reported stronger-than-expected fourth-quarter financial results. Ulta Beauty expects fiscal year 2025 revenue of $11.5 billion to $11.6 billion versus estimates of $11.67 billion, according to Benzinga Pro. The company anticipates full-year earnings of $22.50 to $22.90 per share versus estimates of $23.50 per share.
Losers
- Xponential Fitness, Inc. XPOF shares fell 30.8% to $8.39 in pre-market trading after the company announced fourth-quarter results.
- Linkage Global Inc LGCB declined 21.8% to $0.1797 in pre-market trading.
- Septerna, Inc. SEPN dipped 21.4% to $5.02 in pre-market trading after falling 5% on Thursday.
- Olema Pharmaceuticals, Inc. OLMA fell 15.1% to $3.71 in pre-market trading.
- Icon Energy Corp. ICON shares fell 14.7% to $0.1160 in pre-market trading. ICON Energy received non-compliance letter from the Nasdaq.
- Regencell Bioscience Holdings Limited RGC fell 13.4% to $12.20 in pre-market trading. Relevant Gold closed second tranche of upsized $8.5 million non-brokered private placement led by strategic investors Kinross and Bollinger.
- ImmunoPrecise Antibodies Ltd. IPA fell 11.8% to $0.3572 in today’s pre-market trading. ImmunoPrecise Antibodies shares gained over 11% on Thursday after the company announced a strategic partnership to advance antibody-drug conjugates and bispecific antibodies for cancer.
- SenesTech, Inc SNES shares tumbled 10% to $2.16 in pre-market trading after gaining 5% on Thursday. SenesTech recently reported better-than-expected quarterly EPS results.
- SI-BONE, Inc. SIBN fell 8.2% to $13.51 in pre-market trading. SI-BONE recently reported better-than-expected fourth-quarter EPS results and issued FY25 sales guidance above estimates.
- XPeng Inc. XPEV shares dipped 5.4% to $23.99 in pre-market trading. XPeng recenty announced to spend up to $13.8 billion on humanoid robots.
Now Read This:
Momentum89.66
Growth78.61
Quality–
Value60.84
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.